MarketCap
Pharming Group N.V. PHAR
$ 12.32
-1.68%
Facebook
X
Telegram
Pharming Group N.V. EV - Enterprise Value | PHAR
Annual EV - Enterprise Value Pharming Group N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.8 B | 5.16 B | 6.92 B | 7.67 B | 5.94 B | 8.7 B | 57.2 M | 72.5 M | 147 M | 99.3 M | 33.8 M | 25.9 M | 26.4 M | 24.5 M | 25.9 M |
Annual performance
Select metrics to display
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.8 B | 24.5 M | 3.11 B |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BridgeBio Pharma
BBIO
|
15.5 B | $ 74.28 | 0.01 % | $ 14.2 B |  USA |
 |
BioCryst Pharmaceuticals
BCRX
|
2.8 B | $ 7.69 | 0.72 % | $ 1.61 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
-169 M | $ 3.6 | 3.45 % | $ 249 M |  Britain |
 |
Coherus BioSciences
CHRS
|
335 M | $ 0.77 | 2.9 % | $ 90.2 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 25.59 | -5.24 % | $ 3.26 B | USA |
 |
Cellectis S.A.
CLLS
|
522 M | $ 1.09 | 5.83 % | $ 109 M |  France |
 |
BeyondSpring
BYSI
|
111 M | $ 0.61 | -3.32 % | $ 25.1 M | USA |
 |
Alkermes plc
ALKS
|
5.41 B | $ 45.88 | 3.01 % | $ 7.56 B |  Irlanda |
 |
Altimmune
ALT
|
329 M | $ 2.09 | 6.09 % | $ 184 M | USA |
 |
Cardiff Oncology
CRDF
|
115 M | $ 0.8 | 5.3 % | $ 53.5 M | USA |
 |
Citius Pharmaceuticals
CTXR
|
57.7 M | $ 0.55 | -1.2 % | $ 6.09 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
43.4 M | $ 10.35 | 10.52 % | $ 283 M |  Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
6.02 B | $ 58.16 | 1.22 % | $ 7.78 B | USA |
 |
Incyte Corporation
INCY
|
18.2 B | $ 119.79 | 1.51 % | $ 23.4 B | USA |
 |
Atara Biotherapeutics
ATRA
|
124 M | $ 7.81 | -1.88 % | $ 98 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
1.95 B | $ 16.32 | 0.68 % | $ 2.19 B |  Canada |
 |
Cullinan Management
CGEM
|
850 M | $ 11.37 | 5.28 % | $ 685 M | USA |
 |
BioNTech SE
BNTX
|
17.1 B | $ 87.46 | 1.86 % | $ 21.1 B |  Germany |
 |
Collegium Pharmaceutical
COLL
|
2.52 B | $ 24.19 | -3.86 % | $ 766 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
119 M | $ 3.07 | 7.34 % | $ 40.9 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
434 M | $ 1.26 | -0.79 % | $ 57.6 M | Israel |
 |
AnaptysBio
ANAB
|
1.46 B | $ 46.46 | 1.92 % | $ 1.35 B | USA |
 |
Assembly Biosciences
ASMB
|
301 M | $ 20.43 | 2.17 % | $ 229 M | USA |
 |
Adagene
ADAG
|
176 M | $ 1.99 | -1.73 % | $ 117 M |  China |
 |
Benitec Biopharma
BNTC
|
388 M | $ 9.51 | 10.07 % | $ 443 M | USA |
 |
Denali Therapeutics
DNLI
|
2.34 B | $ 20.09 | 1.88 % | $ 3.47 B | USA |
 |
Amarin Corporation plc
AMRN
|
5.88 B | $ 11.55 | -0.2 % | $ 4.79 B | Irlanda |
 |
Editas Medicine
EDIT
|
218 M | $ 2.57 | 0.59 % | $ 228 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
1.65 B | $ 29.4 | 4.0 % | $ 1.7 B | USA |
 |
Cue Biopharma
CUE
|
18 M | $ 18.93 | 5.11 % | $ 1.79 B | USA |
 |
Equillium
EQ
|
91.1 M | $ 1.54 | 15.79 % | $ 88.2 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
134 M | $ 1.73 | 4.22 % | $ 98.4 M | USA |
 |
Pliant Therapeutics
PLRX
|
80.2 M | $ 0.81 | -0.12 % | $ 49.7 M | USA |
 |
Abeona Therapeutics
ABEO
|
234 M | $ 4.18 | 6.78 % | $ 221 M | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
-115 M | $ 4.36 | 8.19 % | $ 706 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
3.81 B | $ 21.22 | -0.09 % | $ 3.57 B | USA |
 |
PainReform Ltd.
PRFX
|
1.3 M | $ 0.85 | 11.62 % | $ 551 K | Israel |
 |
Jazz Pharmaceuticals plc
JAZZ
|
9.15 B | $ 235.01 | 3.38 % | $ 14.3 B | Irlanda |
 |
Atossa Therapeutics
ATOS
|
13.6 M | $ 2.14 | 5.94 % | $ 18.4 M | USA |
 |
Liquidia Corporation
LQDA
|
3.04 B | $ 44.53 | 0.08 % | $ 3.83 B | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
-29.8 M | - | -7.31 % | $ 49 M | USA |
 |
Five Prime Therapeutics, Inc.
FPRX
|
880 M | - | - | $ 1.77 B | USA |
 |
ADC Therapeutics SA
ADCT
|
386 M | $ 1.59 | -2.16 % | $ 202 M |  Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
1.26 B | $ 33.1 | 1.96 % | $ 1.9 B | USA |
 |
Ardelyx
ARDX
|
1.89 B | $ 2.88 | -3.85 % | $ 694 M | USA |
 |
Akebia Therapeutics
AKBA
|
493 M | $ 0.39 | -7.57 % | $ 100 M | USA |
 |
Alector
ALEC
|
444 M | $ 2.3 | 9.81 % | $ 237 M | USA |
 |
ALX Oncology Holdings
ALXO
|
131 M | $ 1.16 | 0.43 % | $ 62.2 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
4.03 B | $ 20.13 | 3.5 % | $ 6.31 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
847 M | $ 3.65 | -0.54 % | $ 699 M | Canada |